March 27, 2019

House Speaker Nancy Pelosi and the Trump administration are in early talks about possible bipartisan bills to lower prescription drug costs. The discussions are not public, and the White House official who confirmed them would not say what specific bills they were disc...

March 18, 2019

For the well-off the United States has the best health care in the world, with some of the most advanced techniques, medicines, and procedures. But the rising costs of prescription drugs are making this care unaffordable for many Americans, and access is suffering as a...

March 15, 2019

The Department of Health and Human Services's (HHS) proposed rule to get rid of most pharmacy benefit managers (PBM) rebates and require the remaining rebates to be passed on to consumers is an excellent proposal to lower drug costs. However, it is incomplete since thi...

March 13, 2019

This afternoon, in a somewhat technical but very important hearing, the House Energy and Commerce's Health Subcommittee considered seven bills that would promote generic drug competition, reduce brand drug company manipulations of rules and regulations, and lower presc...

March 8, 2019

Yesterday was a banner day for the House of Representatives's drug pricing efforts. Two Committees, the House Ways and Means's Health Subcomittee and the House Judiciary Committee's Antitrust Subcommittee, held hearings on rising drug costs and ways to reduce them. And...

March 6, 2019

Tomorrow the Health Subcommittee of the House Ways and Means Committee is holding a hearing on promoting competition to lower Medicare prescription drug prices. During the hearing, Representatives should ask about a little known practice that encourages health plans to...

Please reload

Featured Posts

United States-Mexico-Canada Agreement (USMCA)

October 5, 2018

1/4
Please reload

Recent Posts
Please reload

Archive